0000950157-26-000280
SEC filingBiogen Inc. filed an 8-K on March 11, 2026, with Items listed as N/A. The external context indicates Item 5.02 related to departure of directors or certain officers, election of directors, appointment of certain officers, or compensatory arrangements, occurring on March 11.